Baxter International (BAX) Income from Non-Controlling Interests (2009 - 2024)
Baxter International (BAX) reported Income from Non-Controlling Interests of -$9.0 million for Q4 2024, down 1000.0% year-over-year from $1.0 million in Q1 2024, and down 325.0% quarter-over-quarter from $4.0 million in Q3 2024.
Baxter International (BAX) Income from Non-Controlling Interests (2009 - 2024) Analysis & Trends
Baxter International (BAX) has 9 years of Income from Non-Controlling Interests data on file, last reported at -$9.0 million in Q4 2024.
- Income from Non-Controlling Interests for Q4 2024 came in at -$9.0 million, down 1000.0% year-over-year; the trailing twelve-month figure through Sep 2025 was -$9.0 million (down 190.0% YoY), and the FY2023 annual result was $7.0 million, down 41.67% from the prior year.
- Income from Non-Controlling Interests slipped to -$9.0 million in Q4 2024 per BAX's latest filing, from $4.0 million in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at $4.0 million in Q4 2021 and troughed at -$9.0 million in Q4 2024.
- A 5-year average of $1.9 million and a median of $2.5 million in 2020 frame the typical range for Income from Non-Controlling Interests.
- The sharpest annual moves came in 2021 and 2024: Income from Non-Controlling Interests jumped 200.0% in 2021, then slumped 1000.0% in 2024.
- A 5-year view of Income from Non-Controlling Interests shows it stood at $3.0 million in 2020, then soared by 33.33% to $4.0 million in 2021, then changed by 0.0% to $4.0 million in 2022, then sank by 75.0% to $1.0 million in 2023, then tumbled by 1000.0% to -$9.0 million in 2024.
- Business Quant data shows BAX's Income from Non-Controlling Interests at -$9.0 million in Q4 2024, $4.0 million in Q3 2024, and $3.0 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 5.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 105.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 89,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -9.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 3.00 Mn |
| Jun 30, 2023 | 2.00 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 4.00 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Jun 30, 2022 | 3.00 Mn |
| Mar 31, 2022 | 2.00 Mn |
| Dec 31, 2021 | 4.00 Mn |
| Sep 30, 2021 | 2.00 Mn |
| Jun 30, 2021 | 3.00 Mn |
| Mar 31, 2021 | 2.00 Mn |
| Dec 31, 2020 | 3.00 Mn |
| Sep 30, 2020 | 3.00 Mn |
| Jun 30, 2020 | 1.00 Mn |
| Mar 31, 2020 | 1.00 Mn |